Resources Press News Resources Webinars Events March 14, 2023 Ajinomoto Bio-Pharma Services Awarded Three ‘CDMO Leadership Awards’ Read more February 22, 2023 Ajinomoto Bio-Pharma Services Successfully Develops Highly Functional Ancestral RNA Ligase Read more January 10, 2023 Ajinomoto and Exelixis Enter Into a License Agreement to Discover and Develop Novel Antibody-Drug Conjugates for the Treatment of Cancer Read more September 26, 2022 Notice of Qualified Invoice Issuer Registration Number GeneDesign, Inc. – Osaka SiteRead more March 3, 2022 Ajinomoto Bio-Pharma Services Awarded Two ‘CMO Leadership Awards’ Read more January 25, 2022 Tony O’Neill Joins Ajinomoto Bio-Pharma Services’ Leadership Team as Vice President of Compliance Read more January 11, 2022 Notice on email address (for business use) changing Read more November 22, 2021 Notice on email address changing GeneDesign, Inc. – Osaka SiteRead more November 10, 2021 [Reminder] Notice on email address domain changing Read more May 25, 2021 Ajinomoto Bio-Pharma Services Expands Fill Finish Capacity with New Multi-Purpose Fill Suite Read more March 30, 2021 Ajinomoto Bio-Pharma Services Expands Manufacturing Agreement with AstraZeneca to Include Drug Product Manufacturing Read more March 29, 2021 Ajinomoto Co., Inc. and Bright Peak Therapeutics Inc. Enter into a Research Collaboration and License Agreement to Create Novel Immunocytokines Read more Loading…Load More July 31, 2026 CDMOs Forge Links to Next-Gen Antibody Conjugates July 31, 2026 Manufacturing Materials for Clinical Trials – An Interview July 31, 2026 Speeding Development and Manufacturing of Materials for Clinical Trials – An Interview July 31, 2026 Emphasizing Sustainability in Contract Manufacturing – An Interview July 31, 2026 Panel Discussion – Part III: CDMO Strategy in a COVID-19 World July 31, 2026 Application of Native Ion Exchange Mass Spectrometry to Intact and Subunit Analysis of Site-Specific Antibody–Drug Conjugates Produced by AJICAP First Generation Technology July 31, 2026 Interview – A CDMO for the Future: Adapting Services for Evolving Needs July 31, 2026 Good Manufacturing Practice Strategy for Antibody–Drug Conjugate Synthesis Using Site-Specific Chemical Conjugation: First-Generation AJICAP July 31, 2026 Contract Pharma’s 20th Anniversary Retrospective Loading…Load More November 3, 2022 Leveraging CDMO’s in Pharma’s Drive Towards Net Zero Read more July 1, 2022 Sedimentation Behavior of Suspensions in Milliflow Reactors Read more March 14, 2022 Webinar Summary: The Paradigm Shift to Continuous Flow Processes Read more March 14, 2022 Q&A: The Paradigm Shift to Continuous Flow Processes Read more July 19, 2021 Ensuring Quality Oversight In Plasmid DNA Manufacturing Read more June 24, 2021 Plasmid DNA CGMP Production: Finding The Right Manufacturing Partner Read more June 10, 2021 Q&A With Aji Bio-Pharma: Plasmid Manufacturing for Gene Therapies Read more March 17, 2021 Comparative Approaches for the Analysis of a Site-Specific ADC Produced by AJICAP Technology Read more March 17, 2021 Good Manufacturing Practices Strategy Applied to ADC Synthesis Produced by Site-Specific Chemical Conjugation: AJICAP Technology Read more March 17, 2021 Introduction of 2nd Generation AJICAP Technology – Expansion of Chemical Site-Specific Conjugation Capabilities Read more March 17, 2021 Process Development and Biological Evaluation of Antibody Drug Conjugate Based on a Novel Site-Specific Chemical Conjugation Platform Read more March 17, 2021 Process Development and Good Manufacturing Practice Strategy for Antibody-Drug Conjugate Produced by AJICAP Technology Read more Loading…Load More November 18, 2025 Webinar – Engineering the Future of API Manufacturing: A Scientific Approach to Continuous Flow July 3, 2024 Webinar – You Had Me At Flow: The Shift From Batch To Continuous March 13, 2024 Webinar – Breaking Bad Manufacturing Habits: Strategies For Sustainable API Production November 28, 2023 Plasmid Production: The Benefits of Working with an Experienced CDMO May 9, 2023 Strategies for Scaling HPAPI Production Webinar December 5, 2022 Sustainable Approaches to Oligonucleotide Manufacturing January 10, 2022 The Paradigm Shift to Continuous Flow Processes: A Holistic View May 12, 2021 Plasmid Manufacturing for Gene Therapies: An Outsourcing Partnership Duration January 28, 2021 Oligonucleotide Therapeutics: Bridging from Research to Commercial Loading…Load More August 4, 2026 Oligonucleotide-Based Therapeutics Conference August 4, 2026 The Bioprocessing Summit 2026